U01DA052783
Cooperative Agreement
Overview
Grant Description
Interrogating genome folding trajectories in health and disease.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
New York,
New York
10027
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 400% from $622,658 to $3,113,290.
The Trustees Of Columbia University In The City Of New York was awarded
Interrogating genome folding trajectories in health and disease
Cooperative Agreement U01DA052783
worth $3,113,290
from the National Institute of Allergy and Infectious Diseases in September 2020 with work to be completed primarily in New York New York United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 8/20/24
Period of Performance
9/30/20
Start Date
8/31/25
End Date
Funding Split
$3.1M
Federal Obligation
$0.0
Non-Federal Obligation
$3.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01DA052783
Transaction History
Modifications to U01DA052783
Additional Detail
Award ID FAIN
U01DA052783
SAI Number
U01DA052783-3661045074
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N600 NIH NATIONAL INSITUTE ON DRUG ABUSE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
QHF5ZZ114M72
Awardee CAGE
3FHD3
Performance District
NY-13
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,867,974 | 100% |
Modified: 8/20/24